(Q35193467)

7 August 2017

1 reference

title

Tuberculosis vaccines: the past, present and future (English)

1 reference

7 August 2017

0 references

Jun Wang

1

1 reference

7 August 2017

Zhou Xing

series ordinal

2

1 reference

7 August 2017

language of work or name

1 reference

1 October 2002

1 reference

Expert Review of Vaccines

7 August 2017

published in

1 reference

7 August 2017

volume

1

1 reference

7 August 2017

issue

3

1 reference

7 August 2017

page(s)

341-354

1 reference

Variation in protection by BCG: implications of and for heterologous immunity

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.341

Immunology of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.341

How can immunology contribute to the control of tuberculosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.341

Identification and characterization of murine cytotoxic T cells that kill Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.341

An antimicrobial activity of cytolytic T cells mediated by granulysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.341

Impairment of immunological memory in the absence of MHC despite survival of memory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.341

TB vaccines: progress and problems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.341

Enhanced immunogenicity of BCG vaccine by using a viral-based GM-CSF transgene adjuvant formulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.341

Failure to induce enhanced protection against tuberculosis by increasing T-cell-dependent interferon-gamma generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.341

Mycobacterial antigens exacerbate disease manifestations in Mycobacterium tuberculosis-infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.341

Comparative genomics of BCG vaccines by whole-genome DNA microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.341

Cellular immune responses to mycobacteria in healthy and human immunodeficiency virus-positive subjects in the United States after a five-dose schedule of Mycobacterium vaccae vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.341

Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.341

DNA vaccination against tuberculosis: expression of a ubiquitin-conjugated tuberculosis protein enhances antimycobacterial immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.341

Vaccination against tuberculosis by DNA injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.341

Therapy of tuberculosis in mice by DNA vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.341

CpG motifs in bacterial DNA and their immune effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.341

Therapeutic perspectives of in vivo cell electropermeabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.341

The efficacy of genetic vaccination is dependent upon the nature of the vector system and antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.341

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.341

Oral vaccination with subunit vaccines protects animals against aerosol infection with Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.341

BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.341

Tuberculosis subunit vaccine development: on the role of interferon-γ

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.3.341

21 January 2018

Identifiers

DOI

10.1586/14760584.1.3.341

1 reference

7 August 2017

1 reference